Details for: CYRIB
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 79.37rCSI 73.23%PRS 12.03
-
CSI 78.47rCSI 97.63%PRS 6.42
-
CSI 72.04rCSI 92.86%PRS 7.26
-
CSI 69.03rCSI 82.46%PRS 6.78
-
CSI 65.2rCSI 50.23%PRS 10.74
-
CSI 56.33rCSI 90.59%PRS 7.66
-
CSI 56.06rCSI 94.09%PRS 6.92
-
CSI 52.72rCSI 76.37%PRS 17.44
-
CSI 52.55rCSI 92.81%PRS 6.93
-
CSI 44.79rCSI 81.39%PRS 9.66
-
CSI 40.52rCSI 76.49%PRS 14.71
-
CSI 40.41rCSI 33.74%PRS 34.81
-
CSI 38.82rCSI 58.58%PRS 11.68
-
CSI 38.76rCSI 48.64%PRS 15.09
-
CSI 37.55rCSI 91.25%PRS 6.74
-
CSI 36.72rCSI 44.35%PRS 13.89
-
CSI 34.64rCSI 100%PRS 10.11
-
CSI 31.87rCSI 29.26%PRS 13.54
-
CSI 31.79rCSI 84.66%PRS 9.26
-
CSI 30.55rCSI 95.54%PRS 7.99
-
CSI 29.36rCSI 50.3%PRS 15.85
-
CSI 29.33rCSI 91.65%PRS 7.43
-
CSI 29.09rCSI 35.99%PRS 10.41
-
CSI 28.63rCSI 62.1%PRS 6.17
-
CSI 27.33rCSI 19.08%PRS 12.41
-
CSI 26.04rCSI 93.69%PRS 6.4
-
CSI 24.85rCSI 40.7%PRS 9.15
-
CSI 24.25rCSI 83.05%PRS 10.67
-
CSI 23.97rCSI 90.58%PRS 7.08
-
CSI 23.04rCSI 55.11%PRS 6.39
-
CSI 21.98rCSI 72.23%PRS 5.93
-
CSI 21.92rCSI 33.48%PRS 11.85
-
CSI 21.7rCSI 47.93%PRS 8.51
-
CSI 19.22rCSI 34.97%PRS 46.45
-
CSI 18.38rCSI 40.44%PRS 6.4
-
CSI 17.96rCSI 72.29%PRS 30.19
-
CSI 17.69rCSI 11.79%PRS 31.03
-
CSI 16.13rCSI 19.87%PRS 37.68
-
CSI 15.65rCSI 72.27%PRS 24.68
-
CSI 14.94rCSI 87.99%PRS 7.27
-
CSI 14.7rCSI 11.43%PRS 17.1
-
CSI 14.12rCSI 21.56%PRS 20.67
-
CSI 13.66rCSI 21.12%PRS 11.11
-
CSI 13.46rCSI 34.14%PRS 9.06
-
CSI 13.3rCSI 29.13%PRS 15.87
-
CSI 12.56rCSI 8.46%PRS 14.21
-
CSI 12.44rCSI 26.31%PRS 24.24
-
CSI 12.22rCSI 89.78%PRS 5.94
-
CSI 11.95rCSI 31.16%PRS 11.05
-
CSI 11.33rCSI 20.49%PRS 31.91
-
CSI 11.21rCSI 32%PRS 20.58
-
CSI 10.8rCSI 14.72%PRS 28.54
-
CSI 10.6rCSI 27.39%PRS 11.04
-
CSI 10.59rCSI 24.22%PRS 11.44
-
CSI 10.11rCSI 9.74%PRS 12.26
-
CSI 10.11rCSI 15.46%PRS 19.29
-
CSI 10.07rCSI 41.83%PRS 16.4
-
CSI 9.9rCSI 29.39%PRS 17.7
-
CSI 9.69rCSI 12.19%PRS 18.14
-
CSI 9.44rCSI 21.78%PRS 9.63
-
CSI 9.36rCSI 80.62%PRS 3.55
-
CSI 9.34rCSI 19.2%PRS 12.11
-
CSI 9.21rCSI 51.55%PRS 25.39
-
CSI 9.2rCSI 13.21%PRS 9.32
-
CSI 8.55rCSI 32.05%PRS 10.07
-
CSI 8.3rCSI 50.22%PRS 26.55
-
CSI 8.28rCSI 7.27%PRS 13.3
-
CSI 8.14rCSI 8.24%PRS 59.11
-
CSI 8.07rCSI 67.9%PRS 12.14
-
CSI 7.95rCSI 5.95%PRS 19.22
-
CSI 7.43rCSI 9.24%PRS 12.53
-
CSI 7.32rCSI 24.54%PRS 8.36
-
CSI 6.92rCSI 7.05%PRS 16.93
-
CSI 6.71rCSI 17.47%PRS 11.8
-
CSI 6.7rCSI 45.57%PRS 11.96
-
CSI 6.5rCSI 92.3%PRS 8.13
-
CSI 6.49rCSI 8.92%PRS 24.44
-
CSI 6.46rCSI 18.71%PRS 9.32
-
CSI 6.33rCSI 4.75%PRS 33.9
-
CSI 6.11rCSI 5.51%PRS 10.46
-
CSI 6.1rCSI 3.6%PRS 16.31
-
CSI 6.03rCSI 4.23%PRS 31.07
-
CSI 5.97rCSI 8.46%PRS 11.06
-
CSI 5.92rCSI 93.33%PRS 5.7
-
CSI 5.92rCSI 5.84%PRS 45.07
-
CSI 5.88rCSI 29.25%PRS 13.04
-
CSI 5.8rCSI 12.76%PRS 18.18
-
CSI 5.79rCSI 32.59%PRS 37.32
-
CSI 5.76rCSI 7.39%PRS 12.2
-
CSI 5.63rCSI 10.84%PRS 26.5
-
CSI 5.61rCSI 7.5%PRS 15.79
-
CSI 5.52rCSI 8.85%PRS 36.43
-
CSI 5.52rCSI 4.46%PRS 19.91
-
CSI 5.47rCSI 3.8%PRS 16.87
-
CSI 5.38rCSI 6.16%PRS 24.31
-
CSI 5.36rCSI 6.86%PRS 47.53
-
CSI 5.11rCSI 12.18%PRS 14.4
-
CSI 5.09rCSI 16.67%PRS 33.41
-
CSI 4.95rCSI 5.72%PRS 10.44
-
CSI 4.93rCSI 3.28%PRS 14.13
-
CSI -4.4rCSI -23.5%PRS 21.4%
-
CSI -2.2rCSI -1.7%PRS 12.3%
-
CSI -2.0rCSI -4.6%PRS 12.4%
-
CSI -1.4rCSI -1.6%PRS 15.9%
-
CSI -1.3rCSI -2.2%PRS 11.8%
-
CSI -1.0rCSI -2.4%PRS 15.0%
-
CSI -0.9rCSI -4.4%PRS 15.5%
-
CSI -0.8rCSI -4.9%PRS 9.3%
-
CSI -0.8rCSI -1.1%PRS 13.4%
-
CSI -0.7rCSI -11.3%PRS 46.6%
-
CSI -0.3rCSI -0.4%PRS 11.7%
-
CSI -0.3rCSI -0.7%PRS 34.8%
-
CSI -0.1rCSI -1.0%PRS 21.9%
-
CSI 0.0rCSI 0.1%PRS 17.0%
-
CSI 0.1rCSI 0.3%PRS 19.4%
-
CSI 0.1rCSI 0.5%PRS 8.7%
-
CSI 0.2rCSI 3.4%PRS 58.3%
-
CSI 0.2rCSI 4.1%PRS 38.1%
-
CSI 0.2rCSI 0.4%PRS 17.9%
-
CSI 0.2rCSI 0.4%PRS 12.1%
-
CSI 0.2rCSI 0.9%PRS 15.4%
-
CSI 0.2rCSI 2.0%PRS 22.9%
-
CSI 0.2rCSI 0.7%PRS 19.4%
-
CSI 0.2rCSI 2.0%PRS 66.9%
-
CSI 0.2rCSI 0.6%PRS 23.1%
-
CSI 0.2rCSI 1.1%PRS 21.3%
-
CSI 0.2rCSI 1.2%PRS 39.7%
-
CSI 0.2rCSI 1.9%PRS 12.0%
-
CSI 0.3rCSI 0.5%PRS 27.9%
-
CSI 0.3rCSI 0.9%PRS 37.0%
-
CSI 0.3rCSI 3.2%PRS 46.0%
-
CSI 0.3rCSI 2.7%PRS 4.7%
-
CSI 0.3rCSI 1.4%PRS 22.1%
-
CSI 0.3rCSI 1.5%PRS 11.7%
-
CSI 0.4rCSI 0.5%PRS 16.6%
-
CSI 0.4rCSI 1.2%PRS 17.4%
-
CSI 0.4rCSI 0.5%PRS 18.6%
-
CSI 0.4rCSI 0.5%PRS 13.0%
-
CSI 0.4rCSI 0.5%PRS 6.7%
-
CSI 0.4rCSI 3.1%PRS 10.6%
-
CSI 0.4rCSI 0.6%PRS 16.3%
-
CSI 0.4rCSI 0.5%PRS 20.3%
-
CSI 0.4rCSI 2.0%PRS 4.4%
-
CSI 0.4rCSI 1.0%PRS 11.0%
-
CSI 0.5rCSI 2.6%PRS 17.3%
-
CSI 0.5rCSI 1.9%PRS 17.1%
-
CSI 0.5rCSI 1.1%PRS 24.0%
-
CSI 0.5rCSI 2.8%PRS 18.4%
-
CSI 0.5rCSI 1.2%PRS 7.3%
-
CSI 0.5rCSI 0.6%PRS 10.9%
-
CSI 0.5rCSI 3.8%PRS 11.3%
-
CSI 0.5rCSI 1.0%PRS 28.0%
-
CSI 0.6rCSI 2.0%PRS 20.3%
-
CSI 0.6rCSI 1.1%PRS 23.4%
-
CSI 0.6rCSI 3.4%PRS 35.1%
-
CSI 0.6rCSI 0.5%PRS 20.8%
-
CSI 0.6rCSI 1.2%PRS 25.8%
-
CSI 0.6rCSI 0.9%PRS 11.1%
-
CSI 0.6rCSI 5.4%PRS 21.9%
-
CSI 0.7rCSI 3.7%PRS 44.9%
-
CSI 0.7rCSI 1.6%PRS 18.8%
-
CSI 0.7rCSI 0.9%PRS 13.7%
-
CSI 0.7rCSI 0.9%PRS 22.6%
-
CSI 0.7rCSI 2.3%PRS 8.5%
-
CSI 0.7rCSI 1.5%PRS 19.2%
-
CSI 0.7rCSI 4.8%PRS 38.0%
-
CSI 0.8rCSI 2.0%PRS 16.0%
-
CSI 0.8rCSI 1.5%PRS 32.5%
-
CSI 0.8rCSI 1.4%PRS 11.8%
-
CSI 0.8rCSI 0.6%PRS 19.9%
-
CSI 0.8rCSI 1.2%PRS 13.6%
-
CSI 0.9rCSI 4.6%PRS 14.1%
-
CSI 0.9rCSI 1.8%PRS 12.6%
-
CSI 0.9rCSI 0.7%PRS 8.2%
-
CSI 0.9rCSI 1.2%PRS 12.1%
-
CSI 0.9rCSI 1.1%PRS 15.0%
-
CSI 0.9rCSI 5.4%PRS 12.6%
-
CSI 0.9rCSI 2.5%PRS 23.2%
-
CSI 1.0rCSI 1.7%PRS 31.7%
-
CSI 1.0rCSI 4.7%PRS 16.1%
-
CSI 1.0rCSI 1.6%PRS 7.3%
-
CSI 1.0rCSI 0.9%PRS 24.6%
-
CSI 1.0rCSI 6.4%PRS 30.7%
-
CSI 1.0rCSI 3.5%PRS 21.5%
-
CSI 1.0rCSI 6.8%PRS 12.1%
-
CSI 1.0rCSI 4.0%PRS 2.3%
-
CSI 1.0rCSI 0.8%PRS 16.4%
-
CSI 1.0rCSI 1.2%PRS 8.7%
-
CSI 1.0rCSI 1.4%PRS 19.5%
-
CSI 1.1rCSI 12.0%PRS 11.9%
-
CSI 1.1rCSI 2.8%PRS 19.3%
-
CSI 1.1rCSI 1.6%PRS 12.6%
-
CSI 1.1rCSI 2.8%PRS 14.7%
-
CSI 1.2rCSI 6.5%PRS 4.6%
-
CSI 1.2rCSI 5.5%PRS 11.7%
-
CSI 1.2rCSI 7.3%PRS 4.9%
-
CSI 1.2rCSI 1.8%PRS 13.7%
-
CSI 1.2rCSI 7.9%PRS 36.9%
-
CSI 1.2rCSI 2.2%PRS 8.6%
-
CSI 1.3rCSI 1.3%PRS 11.0%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1807891724
Symbol: CYRIB_HUMAN
Name: L1
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11042152
Title: Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.
PubMed ID: 11042152
DOI: 10.1101/gr.140200
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 16421571
Title: DNA sequence and analysis of human chromosome 8.
PubMed ID: 16421571
DOI: 10.1038/nature04406
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 25255805
Title: Global profiling of co- and post-translationally N-myristoylated proteomes in human cells.
PubMed ID: 25255805
DOI: 10.1038/ncomms5919
PubMed ID: 30250061
Title: Fam49/CYRI interacts with Rac1 and locally suppresses protrusions.
PubMed ID: 30250061
PubMed ID: 29059164
Title: FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis.
PubMed ID: 29059164
DOI: 10.1038/onc.2017.358
PubMed ID: 31285585
Title: CYRI/FAM49B negatively regulates RAC1-driven cytoskeletal remodelling and protects against bacterial infection.
PubMed ID: 31285585
Sequence Information:
- Length: 324
- Mass: 36748
- Checksum: EE370E3D170A6E38
- Sequence:
MGNLLKVLTC TDLEQGPNFF LDFENAQPTE SEKEIYNQVN VVLKDAEGIL EDLQSYRGAG HEIREAIQHP ADEKLQEKAW GAVVPLVGKL KKFYEFSQRL EAALRGLLGA LTSTPYSPTQ HLEREQALAK QFAEILHFTL RFDELKMTNP AIQNDFSYYR RTLSRMRINN VPAEGENEVN NELANRMSLF YAEATPMLKT LSDATTKFVS ENKNLPIENT TDCLSTMASV CRVMLETPEY RSRFTNEETV SFCLRVMVGV IILYDHVHPV GAFAKTSKID MKGCIKVLKD QPPNSVEGLL NALRYTTKHL NDETTSKQIK SMLQ